Gold Holds Steady Near Three-month Low

Gold prices held near a three-month low on Friday and were set for their fourth straight weekly fall, as equities rebounded and the dollar held near a fresh 20-year high scaled the previous day.

Spot gold edged up 0.1 percent to $1,824.02 per ounce, while U.S. gold futures were down 0.1 percent at $1,823.12.

The dollar index was a tad lower in European trade, while Treasury yields were on the rise after the U.S. Senate confirmed Jerome Powell for a second four-year term as Federal Reserve Chair.

Powell said in an interview that the battle to control inflation would "include some pain" and the U.S. central bank would manage to tighten borrowing costs without going so far as to tip the economy into recession.

In economic releases, French inflation was confirmed at an annual 5.4 percent in April.

Industrial output in the euro zone fell an annualized 0.8 percent in March versus a -0.6 percent decline expected, Eurostat data showed.

U.S. import and export prices for April and University of Michigan's preliminary consumer sentiment index for May are set for release in the New York session.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT